Concepedia

Author

Lorena Lerner

AVEO Oncology (United States)ORCID

Also Known As

L. Lerner, Lane Lerner, Lorena Lerner, Lorena R. Lerner

78

Publications

1.5K

Citations

15

H-Index

36

Concepts

All Affiliations

AVEO Oncology (United States)Oncor (United States)Rockefeller UniversityUniversity of BergenHaukeland University Hospital
LL

About

Lorena Lerner is an author at AVEO Oncology (United States) specializing in medicine, cancer research, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

603

2

Cell Biology

2

2

303

3

Education

1

1

206

4

Public Health

1

1

39

5

Epidemiology

1

1

39

Lorena Lerner

×

15

Publications

1.5K

Citations

15

H-Index

YearCitations

Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak,

Molecular Cancer Therapeutics

2010

216

Use of Bovine Milk Concentrate Containing Antibody to Rotavirus to Treat Rotavirus Gastroenteritis in Infants

H. Hilpert, H. Briissow, C Mietens,

The Journal of Infectious Diseases

1987

206

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients

Lorena Lerner, Teresa G. Hayes, Nianjun Tao,

Journal of Cachexia Sarcopenia and Muscle

2015

189

MAP3K11/GDF15 axis is a critical driver of cancer cachexia

Lorena Lerner, Julie Tao, Qing Liu,

Journal of Cachexia Sarcopenia and Muscle

2015

174

GP369, an FGFR2-IIIb–Specific Antibody, Exhibits Potent Antitumor Activity against Human Cancers Driven by Activated FGFR2 Signaling

Ailin Bai, Kristan Meetze, Nhi Vo,

Cancer Research

2010

146

STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the α2-macroglobulin gene

Lorena Lerner, Melissa A. Henriksen, Xiaokui Zhang,

Genes & Development

2003

116

Independent and Cooperative Activation of Chromosomal c-fos Promoter by STAT3

Edward Yang, Lorena Lerner, Daniel Besser,

Journal of Biological Chemistry

2003

87

ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity

Brian B. Haines, Agnieszka Denslow, Peter Grzesik,

Cancer Immunology Research

2020

64

Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD

Gunnar Reksten Husebø, Rune Grønseth, Lorena Lerner,

European Respiratory Journal

2017

56

Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss

Lorena Lerner, Jenő Gyuris, Richard Nicoletti,

Oncology Letters

2016

55

Page 1